Sort by
Keyphrases
Clinical History
100%
Prostate Cancer Risk
100%
Docetaxel
100%
Castration-resistant
100%
Therapeutic History
100%
Metastasis
66%
Clinical Characteristics
66%
Age at Diagnosis
66%
Retrospective Review
66%
Significant Predictors
66%
Primary Therapy
66%
Median Survival
66%
Hazard Ratio
33%
Clinical Treatment
33%
Working Diagnosis
33%
Long-term Survival
33%
Medical Records
33%
Cancer Center
33%
Retrospective Analysis
33%
Systemic Therapy
33%
Metastatic Disease
33%
Treatment History
33%
Multi-institutional
33%
Mortality Hazard
33%
Disease Stage
33%
Localized Disease
33%
Early Death
33%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
33%
Institutional Context
33%
Age at Death
33%
Androgen Deprivation Therapy
33%
Hormonal Manipulation
33%
Medicine and Dentistry
Prostate Cancer
100%
Specific Mortality
100%
Metastatic Carcinoma
75%
Docetaxel
75%
Principal Component Analysis
75%
Malignant Neoplasm
25%
Hazard Ratio
25%
Cancer Mortality
25%
Clinician
25%
Medical Record
25%
Systemic Therapy
25%
Localized Disease
25%
Androgen Deprivation Therapy
25%
Treatment History
25%
Nursing and Health Professions
Prostate Cancer
100%
Principal Component Analysis
75%
Docetaxel
75%
Hazard Ratio
25%
Medical Record
25%
Cancer Mortality
25%
Cancer Center
25%
Systemic Therapy
25%
Androgen Deprivation Therapy
25%
Diseases
25%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Docetaxel
75%
Malignant Neoplasm
25%
Cancer Mortality
25%
Androgen
25%
Diseases
25%
Immunology and Microbiology
Cancer Mortality
100%
Medical Record
100%
Neuroscience
Docetaxel
100%
Androgen
33%